We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Find out what to do if you are spiked, or are with someone who has been, and where to get more information.
How investigators and sponsors should manage clinical trials during COVID-19
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance for healthcare professionals on managing specific medicines and medical devices and using them safely.
If you have long COVID there is a range of support available.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Advice on writing clear notices and maximising replies to your FSNs.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Actions that trial sponsors should consider to build resilience into clinical trial design
FCDO travel advice for Iran. Includes safety and security, insurance, entry requirements and legal differences.
Advice and guidance on the health needs of migrant patients from Guyana for healthcare practitioners.
FCDO travel advice for Uruguay. Includes safety and security, insurance, entry requirements and legal differences.
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
FCDO travel advice for Egypt. Includes safety and security, insurance, entry requirements and legal differences.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
The legal requirements to advertise and promote your medicine including the Blue Guide which interprets the law in more detail.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).